TIME ZONES
How to prepare for the 2022 symposium
Neuroblastoma Basics: Dr. Ami Desai from the University of Chicago's Comer Children's Hospital provides a thorough overview of the biology of neuroblastoma, staging, treatment - particularly aimed at newly diagnosed families.Gallery
Photos & videos from our travels.
NPGS 2022 Agenda
Friday 11 November
Welcome
14:00 London Time
Dr. Daniel Morgenstern will welcome you to the event, provide a quick overview of the event platform resources and kick off the event wth the first session.
TREATING HIGH-RISK NEUROBLASTOMA IN 2022 - Where Are We Now?
14:05 -14:30 London Time
Dr. Daniel Morgenstern will give participants an overview of the current landscape for treating high-risk neuroblastoma.
THE CHALLENGE OF CURING HIGH-RISK NEUROBLASTOMA
14:30 -16:20 London Time
- Finding the right treatment, for the right patient with Dr. Jan Molenaar
- Chemoimmunotherapy, a major breakthrough? with Dr. Rajen Mody
- Is an extended induction right for some patients? with Dr. Sara Federico
- High-Risk and Relapsed Neuroblastoma: Toward More Cures and Better Outcomes, 2022 ASCO publication, with Dr. Steve DuBois
Followed by a 45 minute Q&A.
Moderated by Donna Ludwinski.
CAR-T CELL THERAPIES - Where Are We Now?
16:35 -18:25 London Time
- Optimising CAR-T cells against neuroblastoma with Dr. John Anderson
- GD2 specific CAR and interleukin-15 expressing autologous NKT cells with Dr. Andras Heczey
- PHOX2B peptide-specific CAR-T cells with Dr. Mark Yarmarkovich
- GPC2 CAR for neuroblastoma with Dr. Rosa Nguyen
Followed by a 45 minute Q&A.
Moderated by Antonia Palmer
SPECIAL INTEREST TALK - Anti-GD2
18:40 -19:30 London Time
Gregory Sizikov will host this special interest talk with Dr. Robbie Majzner, looking at Anti-GD2, what do we know, what do we still need to understand, what about children without GD2 expression.
SPECIAL INTEREST TALK - TBA
18:40 -19:30 London Time
Jude Sibley will host this special interest talk on survival.
Wrap Up
19:30 London Time
Dr. Daniel Morgenstern provides a summary of the day's presentations and the event closes with a moving tribute to neuroblastoma children from around the world.
